Santhera Pharmaceuticals Holding AG (SPHDF)
18.30
0.00 (0.00%)
USD |
OTCM |
Oct 15, 16:00
Santhera Pharmaceuticals Cash from Operations (TTM) : -0.7361M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7361M |
| December 31, 2025 | -43.47M |
| June 30, 2025 | -47.46M |
| December 31, 2024 | -40.75M |
| June 30, 2024 | 53.56M |
| December 31, 2023 | 53.90M |
| June 30, 2023 | -35.37M |
| December 31, 2022 | -31.19M |
| June 30, 2022 | -33.04M |
| December 31, 2021 | -40.87M |
| June 30, 2021 | -46.49M |
| December 31, 2020 | -46.50M |
| June 30, 2020 | 2.600M |
| December 31, 2019 | 2.872M |
| June 30, 2019 | -36.09M |
| December 31, 2018 | -38.78M |
| June 30, 2018 | -43.63M |
| December 31, 2017 | -40.28M |
| June 30, 2017 | -33.52M |
| December 31, 2016 | -27.55M |
| June 30, 2016 | -29.15M |
| Date | Value |
|---|---|
| December 31, 2015 | -23.13M |
| June 30, 2015 | -11.28M |
| December 31, 2014 | -6.604M |
| June 30, 2014 | -6.002M |
| December 31, 2013 | -7.510M |
| June 30, 2013 | -8.39M |
| December 31, 2012 | -11.66M |
| June 30, 2012 | -17.65M |
| December 31, 2011 | -22.38M |
| June 30, 2011 | -5.224M |
| December 31, 2010 | -5.585M |
| June 30, 2010 | -12.00M |
| December 31, 2009 | -18.30M |
| June 30, 2009 | -37.80M |
| December 31, 2008 | -42.36M |
| June 30, 2008 | -27.84M |
| December 31, 2007 | -16.44M |
| June 30, 2007 | -22.47M |
| December 31, 2006 | -19.09M |
| June 30, 2006 | -4.276M |
| December 31, 2005 | -4.762M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Basilea Pharmaceutica AG | 75.01M |
| BeOne Medicines Ltd. | 1.488B |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -369.58M |
| Idorsia Ltd. | -161.54M |